Medline, Inc. MDLN Cash Flow Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | $979.75M+2.3% | $977M+2.7% | ||
| —— | —— | —— | $64.75M-12.2% | $61M-21.8% | ||
| —— | —— | —— | -$22M+5.4% | -$24M-4.3% | ||
| —— | —— | —— | $57.75M-22.2% | $57M-28.7% | ||
| —— | —— | —— | $73.25M+237% | $63M+688% | ||
| —— | —— | —— | $290M+62.2% | $256M+67.3% | ||
| —— | —— | —— | $337.75M+272% | $545M+223% | ||
| —— | —— | —— | $114.5M-10.9% | $106M-22.1% | ||
| —— | —— | —— | $80.5M+218% | $62M+155% | ||
| —— | —— | —— | -$6.5M-111% | -$46M-150% | ||
| —— | —— | —— | -$75M-87.5% | -$88M-267% | ||
| —— | —— | —— | $10.5M+13.5% | $22M+340% | ||
| -$58M-81.3% | -$51.5M-115% | -$45M-181% | -$38.5M-381% | -$32M— | ||
| —— | —— | —— | $2.01B+17.7% | $1.77B+5.0% | ||
| —— | —— | —— | $363.5M+23.3% | $354M+28.7% | ||
| —— | —— | —— | $838.5M+186% | $1.13B+6,938% | ||
| $0-100% | $750K-85.0% | $1.5M-78.6% | $2.25M-75.0% | $3M-72.7% | ||
| —— | —— | —— | -$1.21B-99.5% | -$1.49B-379% | ||
| —— | —— | —— | $24M+380% | $20M— | ||
| $7.57B-52.5% | $9.66B-19.2% | $11.75B+47.5% | $13.84B+248% | $15.93B— | ||
| —— | —— | —— | $303.5M+631% | $166M— | ||
| —— | —— | —— | —— | —— | ||
| $0-100% | $3M-66.7% | $6M0.0% | $9M+200% | $12M— | ||
| —— | —— | —— | -$1.22B-123% | -$1.61B-745% | ||
| —— | —— | —— | $10.5M+200% | $2M-50.0% | ||
| —— | —— | —— | -$411.25M-174% | -$1.34B-213% | ||
| —— | —— | —— | $902.5M-18.0% | $1.02B-9.2% | ||
| $62M-38.6% | $71.75M-19.2% | $81.5M+6.5% | $91.25M+42.0% | $101M+94.2% | ||
| —— | —— | —— | $57.75M-22.2% | $57M-28.7% | ||
| $0-100% | $6.25M-84.8% | $12.5M-78.3% | $18.75M-74.6% | $25M-72.2% | ||
| $41M— | $30.75M— | $20.5M— | $10.25M— | $0— | ||
| —— | —— | —— | -$21.5M-8,700% | $10M+433% | ||
| —— | —— | —— | -$6.5M-111% | -$46M-150% | ||
| —— | —— | —— | $62.75M+24.3% | $61M+29.8% | ||
| —— | —— | —— | $10.5M+13.5% | $22M+340% | ||
| —— | —— | —— | $73.25M+237% | $63M+688% | ||
| $33M+230% | $27.25M+173% | $21.5M+115% | $15.75M+57.5% | $10M0.0% | ||
| $0-100% | $750K-85.0% | $1.5M-78.6% | $2.25M-75.0% | $3M-72.7% | ||
| $1.97B— | $1.48B— | $985M— | $492.5M— | $0— | ||
| $0-100% | $3M-66.7% | $6M0.0% | $9M+200% | $12M— | ||
| —— | —— | —— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $7.05B— | $5.29B— | $3.52B— | $1.76B— | $0— | ||
| —— | —— | —— | $303.5M+631% | $166M— | ||
| $518M-65.9% | $768M-34.2% | $1.02B+24.8% | $1.27B+173% | $1.52B+1,232% | ||
| $7.57B-52.5% | $9.66B-19.2% | $11.75B+47.5% | $13.84B+248% | $15.93B— | ||
| $115M-19.6% | $122M-15.0% | $129M-10.4% | $136M-5.9% | $143M-1.4% | ||
| —— | —— | —— | $142.5M-16.2% | $170M0.0% | ||
| $62M-38.6% | $71.75M-19.2% | $81.5M+6.5% | $91.25M+42.0% | $101M+94.2% | ||
| $0— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | —— | —— | $0— | $0— | ||
| —— | —— | —— | $0— | $0— | ||
| —— | —— | —— | $1.65B+16.6% | $1.42B+0.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Medline, Inc. generate?
- Medline, Inc. (MDLN) generated $2.0B in operating cash flow over the trailing twelve months.
- What is Medline, Inc. 's free cash flow?
- After $371.0M of capital expenditures, Medline, Inc. 's free cash flow was $1.6B over the trailing twelve months, up 13.8% year over year.
- Where does Medline, Inc. 's cash flow data come from?
- Every line is extracted from Medline, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
